Candy Wilson and other FAU researchers conducted a scoping review that synthesized studies focused on non-pharmacological and non-surgical approaches for women with Polyendocrine Metabolic Syndrome during midlife and reproductive aging. These studies examined lifestyle changes, supplements, chronic pain, and quality of life.
The team found that lifestyle interventions, particularly diet and exercise, are most consistently supported, while evidence for complementary therapies is limited and chronic pain and mental health are understudied. As a result, important questions remain about how best to manage PMOS across the lifespan, particularly in later life stages where cardiometabolic risks are heightened and evidence is limited. “We must reframe PMOS as a lifelong condition that extends beyond the reproductive years,” says Wilson.
View Related Expert Profiles: Go to Source